BioCentury | Apr 15, 2013
Clinical News

Integra Life Sciences Corp. regulatory update

...peptides to treat thrombosis. The patent is one in a series licensed exclusively to IART's Telios Pharmaceuticals Inc....
BioCentury | Jul 16, 2007
Product Development

Discontinued agents

...received 510(k) clearance by FDA as a device in 1996 as a hydrating wound dressing. Telios...
BioCentury | Sep 18, 2000
Tools & Techniques

Tough wounds to heal

...ATIS's Dermagraft engineered skin is still in trials for diabetic ulcers, while products such as Telios Pharmaceuticals Inc....
BioCentury | Nov 10, 1997
Clinical News

Integra LifeSciences Corp. regulatory update

...peptide sequence arginine-glycine-aspartic acid (RGD) to treat thrombosis. The patent is licensed exclusively to IART's Telios Pharmaceuticals Inc....
BioCentury | Nov 10, 1997
Company News

Integra LifeSciences Corp. other research news

...IART subsidiary Telios Pharmaceuticals Inc. (San Diego, Calif.) received a $96,500 grant from the National Cancer Institute to...
BioCentury | Oct 6, 1997
Clinical News

Integra LifeSciences Corp. regulatory update

...the technology to enhance wound healing, has an exclusive license to the patent through its Telios Pharmaceuticals Inc....
BioCentury | Sep 2, 1997
Finance

Biotech sell-offs

...1/18/93 - 63% Cortech Inc. (CRTQ) Bradycor Systemic inflammatory response syndrome (SIRS) 7/21/94 - 63% Telios Pharmaceuticals Inc....
BioCentury | Nov 4, 1996
Finance

The money's in the bank

...52 percent) on the week. The scenario recalls Telios Pharmaceuticals' financing dilemma in late 1994. Telios...
...shares it had closed on two weeks prior. The tender offer ultimately was withdrawn, and Telios...
BioCentury | Jul 22, 1996
Company News

Integra LifeSciences Corp., Merck KGaA, Scripps Research Institute cancer, cardiopulmonary, biomaterial/skin/wound news

...IART's Telios Pharmaceuticals subsidiary filed a patent infringement suit in the U.S. District Court for the...
BioCentury | Jun 24, 1996
Strategy

How Advanced Tissue worked out of a jam

...of working capital, and the landscape around it was littered with failures in related fields: Telios...
Items per page:
1 - 10 of 51
BioCentury | Apr 15, 2013
Clinical News

Integra Life Sciences Corp. regulatory update

...peptides to treat thrombosis. The patent is one in a series licensed exclusively to IART's Telios Pharmaceuticals Inc....
BioCentury | Jul 16, 2007
Product Development

Discontinued agents

...received 510(k) clearance by FDA as a device in 1996 as a hydrating wound dressing. Telios...
BioCentury | Sep 18, 2000
Tools & Techniques

Tough wounds to heal

...ATIS's Dermagraft engineered skin is still in trials for diabetic ulcers, while products such as Telios Pharmaceuticals Inc....
BioCentury | Nov 10, 1997
Clinical News

Integra LifeSciences Corp. regulatory update

...peptide sequence arginine-glycine-aspartic acid (RGD) to treat thrombosis. The patent is licensed exclusively to IART's Telios Pharmaceuticals Inc....
BioCentury | Nov 10, 1997
Company News

Integra LifeSciences Corp. other research news

...IART subsidiary Telios Pharmaceuticals Inc. (San Diego, Calif.) received a $96,500 grant from the National Cancer Institute to...
BioCentury | Oct 6, 1997
Clinical News

Integra LifeSciences Corp. regulatory update

...the technology to enhance wound healing, has an exclusive license to the patent through its Telios Pharmaceuticals Inc....
BioCentury | Sep 2, 1997
Finance

Biotech sell-offs

...1/18/93 - 63% Cortech Inc. (CRTQ) Bradycor Systemic inflammatory response syndrome (SIRS) 7/21/94 - 63% Telios Pharmaceuticals Inc....
BioCentury | Nov 4, 1996
Finance

The money's in the bank

...52 percent) on the week. The scenario recalls Telios Pharmaceuticals' financing dilemma in late 1994. Telios...
...shares it had closed on two weeks prior. The tender offer ultimately was withdrawn, and Telios...
BioCentury | Jul 22, 1996
Company News

Integra LifeSciences Corp., Merck KGaA, Scripps Research Institute cancer, cardiopulmonary, biomaterial/skin/wound news

...IART's Telios Pharmaceuticals subsidiary filed a patent infringement suit in the U.S. District Court for the...
BioCentury | Jun 24, 1996
Strategy

How Advanced Tissue worked out of a jam

...of working capital, and the landscape around it was littered with failures in related fields: Telios...
Items per page:
1 - 10 of 51